Verywell Health on MSN1d
A New FDA-Approved Antibiotic May Help Women With Recurring UTIsIf you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...
The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...
The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...
The Food and Drug Administration has approved a new antibiotic that can treat uncomplicated urinary tract infections, or ...
Despite major changes in the prevalence of antibiotic resistance, the 2011 IDSA guideline for uncomplicated UTI still accurately reflects the efficacy and safety of first-line treatments.
GSK said the U.S. Food and Drug Administration approved its Blujepa oral antibiotic for the treatment of female adults and children with uncomplicated urinary tract infections. The pharmaceutical ...
Blujepa is approved to treat females 12 and older with uncomplicated urinary tract infections, or UTIs. About half of all women will experience a UTI at some point in their lives, and about 30% ...
Generalized symptoms of feeling out of sorts, especially feeling unwell, weak and tired, or irritable and restless were reported by a majority of the women with acute uncomplicated lower UTI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results